Blackstone Inc Autolus Therapeutics PLC Transaction History
Blackstone Inc
- $20.1 Billion
- Q4 2024
A detailed history of Blackstone Inc transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Blackstone Inc holds 20,485,611 shares of AUTL stock, worth $28.3 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
20,485,611
Previous 20,485,611
-0.0%
Holding current value
$28.3 Million
Previous $74.4 Million
35.26%
% of portfolio
0.24%
Previous 0.35%
Shares
2 transactions
Others Institutions Holding AUTL
# of Institutions
110Shares Held
130MCall Options Held
0Put Options Held
116K-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$23 Million73.83% of portfolio
-
Deep Track Capital, LP Greenwich, CT14.2MShares$19.6 Million1.47% of portfolio
-
Avoro Capital Advisors LLC New York, NY9.91MShares$13.7 Million0.34% of portfolio
-
Armistice Capital, LLC New York, NY9.2MShares$12.7 Million0.31% of portfolio
-
Tfg Asset Management Gp LTD Grand Cayman, E98.25MShares$11.4 Million6.34% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $125M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...